Dr. Mehdi Javanbakht

Managing Director at Optimax Access; Former Member of ERG (Evidence Review Group) at NICE; Head of Health Economics at Device Access · Managing Director at Optimax Access · UK

Bio: Mehdi holds a Ph.D. in Health Economics and has over 15+ years of experience in the Health Technology Assessment (HTA) field. He used to work as an Evidence Review Group (ERG) member for NICE. Mehdi has built over 120 health economic evaluation models from scratch for different diseases (Cancer, diabetes, cardiovascular diseases, Ophthalmology, …) and has published over 130 papers in peer-reviewed journals. He has a strong commercial sense and in-depth knowledge of modeling.

Topics: Online Platform for health economics evaluation, a way to provide a strong infrastructure to inform decision-making process in health sector

Speaking at 19th Global Nursing & Patient Safety Summit & Exhibition, 2026-12-08 – 2026-12-09, Kuala Lumpur, Malaysia. See all speakers →